John Wiley and Sons: HPV Status May Affect Risk of Early Death in Patients With Oropharynx Cancer
January 14, 2020
January 14, 2020
HOBOKEN, New Jersey, Jan. 14 -- John Wiley and Sons issued the following news release:
New research indicates that there is a higher risk of early death among patients with oropharynx cancer when not caused by human papillomavirus (HPV), than those whose tumors are HPV-positive. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
"Short-term mortality risks among patients with oropharynx cancer by human papillo . . .
New research indicates that there is a higher risk of early death among patients with oropharynx cancer when not caused by human papillomavirus (HPV), than those whose tumors are HPV-positive. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
"Short-term mortality risks among patients with oropharynx cancer by human papillo . . .